Bruker Co. (NASDAQ:BRKR) Receives $49.20 Consensus Price Target from Analysts

Share on StockTwits

Shares of Bruker Co. (NASDAQ:BRKR) have been given an average recommendation of “Hold” by the fifteen brokerages that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $49.20.

A number of research analysts have issued reports on the company. BidaskClub downgraded Bruker from a “buy” rating to a “hold” rating in a report on Tuesday, August 6th. Barclays reissued a “hold” rating and issued a $44.00 price target on shares of Bruker in a report on Monday, June 24th. Leerink Swann raised Bruker from a “market perform” rating to an “outperform” rating in a report on Friday, May 3rd. Svb Leerink raised Bruker from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $40.00 to $53.00 in a research note on Friday, May 3rd. Finally, Jefferies Financial Group upped their target price on Bruker from $45.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, June 21st.

In other news, CEO Frank H. Laukien sold 400,000 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $41.48, for a total transaction of $16,592,000.00. Following the completion of the transaction, the chief executive officer now directly owns 37,991,030 shares of the company’s stock, valued at approximately $1,575,867,924.40. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 26.50% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Natixis purchased a new stake in shares of Bruker during the second quarter worth approximately $559,000. Harvest Fund Management Co. Ltd increased its position in shares of Bruker by 461.3% during the second quarter. Harvest Fund Management Co. Ltd now owns 6,472 shares of the medical research company’s stock worth $323,000 after purchasing an additional 5,319 shares in the last quarter. Royal Bank of Canada increased its position in shares of Bruker by 12.7% during the second quarter. Royal Bank of Canada now owns 45,827 shares of the medical research company’s stock worth $2,289,000 after purchasing an additional 5,168 shares in the last quarter. UBS Group AG increased its position in shares of Bruker by 612.8% during the second quarter. UBS Group AG now owns 167,115 shares of the medical research company’s stock worth $8,347,000 after purchasing an additional 143,669 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. increased its position in shares of Bruker by 65.7% during the second quarter. Amundi Pioneer Asset Management Inc. now owns 266,167 shares of the medical research company’s stock worth $96,516,000 after purchasing an additional 105,579 shares in the last quarter. 66.44% of the stock is owned by institutional investors and hedge funds.

NASDAQ:BRKR traded down $0.62 during trading hours on Friday, reaching $41.64. The company had a trading volume of 1,775,491 shares, compared to its average volume of 1,216,289. Bruker has a 1-year low of $26.10 and a 1-year high of $51.41. The firm has a market cap of $6.54 billion, a PE ratio of 29.74, a price-to-earnings-growth ratio of 2.10 and a beta of 1.30. The business’s 50 day moving average price is $45.67 and its 200-day moving average price is $42.01. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.19 and a quick ratio of 1.27.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Thursday, August 1st. The medical research company reported $0.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.02. Bruker had a return on equity of 27.10% and a net margin of 9.57%. The company had revenue of $490.20 million during the quarter, compared to the consensus estimate of $477.70 million. During the same period in the previous year, the company posted $0.25 earnings per share. Bruker’s revenue for the quarter was up 10.5% on a year-over-year basis. On average, analysts expect that Bruker will post 1.61 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Stockholders of record on Tuesday, September 3rd will be paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.38%. The ex-dividend date is Friday, August 30th. Bruker’s payout ratio is 11.43%.

Bruker Company Profile

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.

Featured Article: What is a front-end load?

Analyst Recommendations for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Swiss National Bank Buys 4,900 Shares of ChannelAdvisor Corp
Swiss National Bank Buys 4,900 Shares of ChannelAdvisor Corp
Doheny Asset Management CA Buys 960 Shares of AT&T Inc.
Doheny Asset Management CA Buys 960 Shares of AT&T Inc.
Doheny Asset Management CA Buys 2,865 Shares of Xilinx, Inc.
Doheny Asset Management CA Buys 2,865 Shares of Xilinx, Inc.
$1.31 EPS Expected for Microchip Technology Inc.  This Quarter
$1.31 EPS Expected for Microchip Technology Inc. This Quarter
Doheny Asset Management CA Has $387,000 Stock Holdings in Lowe’s Companies, Inc.
Doheny Asset Management CA Has $387,000 Stock Holdings in Lowe’s Companies, Inc.
-$0.63 Earnings Per Share Expected for Instructure Inc  This Quarter
-$0.63 Earnings Per Share Expected for Instructure Inc This Quarter


© 2006-2019 Ticker Report